Loading clinical trials...
Loading clinical trials...
This study seeks to evaluate the efficacy and safety of intepirdine (RVT-101) in patients with dementia with Lewy bodies.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Axovant Sciences Ltd.
NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more
NCT07284290 · Dementia With Lewy Bodies, Parkinson Disease Dementia, and more
NCT06098612 · Parkinson's Disease, Multiple System Atrophy, and more
NCT03672266 · Autistic Disorders Spectrum, Adhd, and more
NCT06785948 · Lewy Body Dementia, Lewy Body Dementia With Behavioral Disturbance, and more
US138
Phoenix, Arizona
US108
Phoenix, Arizona
US139
Sun City, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions